2026-04-02 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and INDIANAPOLIS, April 2, 2026 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces the appointment of David Gill as a Non-Executive Director (NED), as part of Board expansion and succession planning. The appointment is…
